Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SU-11654 inhibits receptor tyrosine kinases, including mutant forms of Kit

Dec. 7, 2001

Phosphoramidate prodrugs enabling enhanced intracellular delivery of drugs

Dec. 7, 2001

MediGene seeks marketing authorization for Leuprogel in Germany

Dec. 7, 2001

Replicons kill human glioma cells in preclinical study

Dec. 7, 2001

Expression of mda-7 gene downregulated in advanced human melanomas; INGN-241 blocks growth

Dec. 5, 2001

Regulatory update on Glivec/Gleevec

Dec. 5, 2001

Praecis proceeds with clinical plans for Plenaxis following discussions with the FDA

Dec. 5, 2001

Encouraging results from phase I study of inhalable leuprolide

Dec. 5, 2001

Abgenix licenses novel cancer target for development of potential antibody therapies

Dec. 5, 2001

Novel compositions and methods for gene therapy described in recent patent

Dec. 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...